Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Aug 27, 2022; 14(8): 788-798
Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.788
Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.788
Table 3 Multivariate analysis of adenocarcinoma of the esophagogastric junction (types II and III) patients
Characteristic | Coefficient | HR (95%CI) | P value |
TNM stage | 0.827 | 2.286 (1.236, 4.227) | 0.008 |
BMI | -0.470 | 0.625 (0.413, 0.946) | 0.026 |
NLR | 1.092 | 2.979 (1.565, 5.674) | 0.001 |
CEA | 0.008 | 1.008 (0.997, 1.019) | 0.143 |
Age | 0.031 | 0.970 (0.556, 1.691) | 0.914 |
Tumor size | 0.143 | 1.154 (0.651, 2.045) | 0.624 |
PNI | 0.347 | 1.415 (0.783, 2.557) | 0.250 |
PLR | 0.040 | 1.041 (0.567, 1.912) | 0.897 |
Hemoglobin | 0.197 | 0.821 (0.479, 1.408) | 0.474 |
Prealbumin | 0.122 | 0.885 (0.496, 1.578) | 0.678 |
Differentiation grade | 0.073 | 1.075 ( 0.630, 1.836) | 0.791 |
Cancerous node | 0.084 | 1.088 (0.587, 2.016) | 0.789 |
- Citation: Wei ZJ, Qiao YT, Zhou BC, Rankine AN, Zhang LX, Su YZ, Xu AM, Han WX, Luo PQ. Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction. World J Gastrointest Surg 2022; 14(8): 788-798
- URL: https://www.wjgnet.com/1948-9366/full/v14/i8/788.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i8.788